Literature DB >> 17923610

Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?

Maria Trojano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923610     DOI: 10.1212/01.wnl.0000275545.08382.82

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

Review 1.  Postmarketing evidence of disease-modifying drugs in multiple sclerosis.

Authors:  Maria Trojano; Damiano Paolicelli; Aurora Fuiani; Fabio Pellegrini; Pietro Iaffaldano; Vita Direnzo; Mariangela D'Onghia
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

2.  Estimating typical multiple sclerosis disability progression speed from clinical observations.

Authors:  Murray G Brown; Mark Asbridge; Vern Hicks; Sarah Kirby; Thomas J Murray; Pantelis Andreou; Dong Lin
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.